Molecular Response Providing SuperGen Access to Technologies

Pharmaceutical firm SuperGen will have limited access to Molecular Response's "living" cell bank of primary tumor cells, high-content imaging, and molecular characterization platforms.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.